How the treatment of interleukin-6-driven diseases can be refined

Дата публикации: 25-09-2026 16:20:12

Interleukin-6 (IL-6) is a contradictory molecule in immunology. It helps the liver regenerate after injury and protects against infections, yet it also drives chronic inflammation in rheumatic diseases, inflammatory bowel disease and atherosclerosis. Current drugs block IL-6 across the board: They protect against inflammation but also switch off its beneficial functions.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Selective rather than blanket: How the treatment of interleukin-6-driven diseases can be refined	0	6.57	25-09-2026
2	Selektiv statt pauschal: Wie sich die Behandlung Interleukin-6-getriebener Krankheiten verfeinern lässt	0	7.2	25-09-2026
3	Key gut protein balances immune protection and tolerance	6	7	07-07-2026
4	Decades old puzzle solved as scientists uncover cause of inflammatory bowel disease	0	8.4	11-06-2026
5	Scientists discover how gut bacteria “train” the intestine to fight inflammation	0	10.68	21-08-2026
6	Scientists remove “zombie” cells and reverse liver damage in mice	0	5.92	16-04-2026
7	Modified cell vesicles trigger 'lipid counterstorm' against lung inflammation in mice	0	8.49	31-07-2026
8	Gut protein mapping captures microbial and host responses during intestinal inflammation	0	6.51	03-08-2026
9	Drug candidate treats severe fatty liver disease by protecting the gut in animal models	2	7	07-07-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 6.94. Источник: medicalxpress.com.